The mission of Alcon is to provide innovative products that enhance quality of life by helping people see better. Alcon was founded in 1945, and has grown from a small ophthalmic shop to a global leader in eye care and the second-largest division of Novartis, one of the most successful and respected healthcare companies in the world. Through the 2011 merger of Novartis and Alcon, uniting the strengths of Alcon, CIBA VISION and Novartis Ophthalmics into one eye care business, Alcon now offers the widest spectrum of eye care products across 180 markets, with operations in 75 countries.Alcon has more than 23,000 associates who strive to make significant contributions to preserve, restore and enhance vision worldwide, with a product portfolio serving the full life cycle of eye care needs. From a child’s first contact lens for nearsightedness to a grandparent’s intraocular lens implantation for cataract correction,Alcon innovations help people of all ages see the world more clearly.Alcon is organized in three business franchises: Surgical, Pharmaceutical and Vision Care. The company’s Surgical portfolio includes technologies and devices for cataract, retinal and glaucoma surgery, as well as Lasik surgery for the treatment of refractive errors, like presbyopia and astigmatism. The Pharmaceutical portfolio includes the most advanced treatments for glaucoma, eye infections and inflammation, ocular allergies, dry eye, and ear infections. Through the integration of CIBA VISION, the Alcon Vision Care franchise is now one of the largest manufacturers of contact lenses and lens care products.
The mission of Alcon is to provide innovative products that enhance quality of life by helping people see better. Alcon was founded in 1945, and has grown from a small ophthalmic shop to a global leader in eye care and the second-largest division of Novartis, one of the most successful and respected healthcare companies in the world. Through the 2011 merger of Novartis and Alcon, uniting the strengths of Alcon, CIBA VISION and Novartis Ophthalmics into one eye care business, Alcon now offers the widest spectrum of eye care products across 180 markets, with operations in 75 countries.Alcon has more than 23,000 associates who strive to make significant contributions to preserve, restore and enhance vision worldwide, with a product portfolio serving the full life cycle of eye care needs. From a child’s first contact lens for nearsightedness to a grandparent’s intraocular lens implantation for cataract correction,Alcon innovations help people of all ages see the world more clearly.Alcon is organized in three business franchises: Surgical, Pharmaceutical and Vision Care. The company’s Surgical portfolio includes technologies and devices for cataract, retinal and glaucoma surgery, as well as Lasik surgery for the treatment of refractive errors, like presbyopia and astigmatism. The Pharmaceutical portfolio includes the most advanced treatments for glaucoma, eye infections and inflammation, ocular allergies, dry eye, and ear infections. Through the integration of CIBA VISION, the Alcon Vision Care franchise is now one of the largest manufacturers of contact lenses and lens care products.
The mission of Alcon is to provide innovative products that enhance quality of life by helping people see better. Alcon was founded in 1945, and has grown from a small ophthalmic shop to a global leader in eye care and the second-largest division of Novartis, one of the most successful and respected healthcare companies in the world. Through the 2011 merger of Novartis and Alcon, uniting the strengths of Alcon, CIBA VISION and Novartis Ophthalmics into one eye care business, Alcon now offers the widest spectrum of eye care products across 180 markets, with operations in 75 countries.Alcon has more than 23,000 associates who strive to make significant contributions to preserve, restore and enhance vision worldwide, with a product portfolio serving the full life cycle of eye care needs. From a child’s first contact lens for nearsightedness to a grandparent’s intraocular lens implantation for cataract correction,Alcon innovations help people of all ages see the world more clearly.Alcon is organized in three business franchises: Surgical, Pharmaceutical and Vision Care. The company’s Surgical portfolio includes technologies and devices for cataract, retinal and glaucoma surgery, as well as Lasik surgery for the treatment of refractive errors, like presbyopia and astigmatism. The Pharmaceutical portfolio includes the most advanced treatments for glaucoma, eye infections and inflammation, ocular allergies, dry eye, and ear infections. Through the integration of CIBA VISION, the Alcon Vision Care franchise is now one of the largest manufacturers of contact lenses and lens care products.